Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.7%

53 terminated/withdrawn out of 931 trials

Success Rate

92.1%

+5.6% vs industry average

Late-Stage Pipeline

8%

79 trials in Phase 3/4

Results Transparency

52%

321 of 621 completed trials have results

Key Signals

148 recruiting321 with results34 terminated19 withdrawn

Enrollment Performance

Analytics

N/A
467(54.3%)
Phase 2
205(23.8%)
Phase 1
83(9.7%)
Phase 4
53(6.2%)
Early Phase 1
26(3.0%)
Phase 3
26(3.0%)
860Total
N/A(467)
Phase 2(205)
Phase 1(83)
Phase 4(53)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (931)

Showing 20 of 931 trials
NCT05509166Not ApplicableRecruiting

Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health

Role: collaborator

NCT07060638Phase 2Recruiting

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

Role: collaborator

NCT05011903Not ApplicableNot Yet Recruiting

Integrative Alcohol and Risky Sex Feedback for College Students

Role: collaborator

NCT02233868Early Phase 1Completed

Brain Inflammation and Function in Alcoholism

Role: lead

NCT06318975Not ApplicableRecruiting

Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use

Role: collaborator

NCT02181569Completed

Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study

Role: collaborator

NCT06934395Not ApplicableActive Not Recruiting

SHARE Program: SUSTAIN

Role: collaborator

NCT05564663Not ApplicableActive Not Recruiting

Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes

Role: collaborator

NCT03575403Phase 1Completed

Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)

Role: collaborator

NCT03845205Not ApplicableRecruiting

Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH

Role: collaborator

NCT07342504Not ApplicableRecruiting

Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment

Role: collaborator

NCT07573540Not ApplicableRecruiting

Optimizing Smart Technology for Addiction Recovery

Role: collaborator

NCT06249386Not ApplicableCompleted

Adapting and Piloting Behavioral Activation for Veterans With Alcohol Use Disorder and Posttraumatic Stress Disorder

Role: collaborator

NCT06136195Phase 1Recruiting

Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers

Role: collaborator

NCT00713492Phase 1Completed

Computer-Assisted Self-Administration of Ethanol

Role: lead

NCT02311374Early Phase 1Completed

Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness

Role: lead

NCT03407079Phase 2Recruiting

Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)

Role: lead

NCT03588754Phase 2Suspended

Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?

Role: collaborator

NCT06326684Early Phase 1Recruiting

Suvorexant and Alcohol

Role: collaborator

NCT07029529Phase 2Recruiting

Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder

Role: collaborator